Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Antihemophilic Factor Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Antihemophilic Factor Drugmarket, defines the market attractiveness level of Antihemophilic Factor Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Antihemophilic Factor Drug industry, describes the types of Antihemophilic Factor Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Antihemophilic Factor Drug market and the development prospects and opportunities of Antihemophilic Factor Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Antihemophilic Factor Drug market in Chapter 13.
By Player:
Grifols
Cigna
Bayer
Hualan Biological Engineering
Octapharma
CSL Behring
Novo Nordisk
Shire
GC Pharma
Pfizer
Sanofi
Shanghai RAAS blood products
By Type:
250 IU
500 IU
1000 IU
1500 IU
2000 IU
3000 IU
4000 IU
Other potencies
By End-User:
Adult
Pediatric
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Antihemophilic Factor Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Antihemophilic Factor Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Antihemophilic Factor Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Antihemophilic Factor Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Antihemophilic Factor Drug Market Analysis and Outlook to 2022
-
7.1 Global Antihemophilic Factor Drug Consumption (2017-2022)
-
7.2 United States Antihemophilic Factor Drug Consumption (2017-2022)
-
7.3 Europe Antihemophilic Factor Drug Consumption (2017-2022)
-
7.4 China Antihemophilic Factor Drug Consumption (2017-2022)
-
7.5 Japan Antihemophilic Factor Drug Consumption (2017-2022)
-
7.6 India Antihemophilic Factor Drug Consumption (2017-2022)
-
7.7 South Korea Antihemophilic Factor Drug Consumption (2017-2022)
8 Region and Country-wise Antihemophilic Factor Drug Market Analysis and Outlook to 2028
-
8.1 Global Antihemophilic Factor Drug Consumption Forecast (2022-2028)
-
8.2 United States Antihemophilic Factor Drug Consumption Forecast (2022-2028)
-
8.3 Europe Antihemophilic Factor Drug Consumption Forecast (2022-2028)
-
8.4 China Antihemophilic Factor Drug Consumption Forecast (2022-2028)
-
8.5 Japan Antihemophilic Factor Drug Consumption Forecast (2022-2028)
-
8.6 India Antihemophilic Factor Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Antihemophilic Factor Drug Consumption Forecast (2022-2028)
9 Global Antihemophilic Factor Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Antihemophilic Factor Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global 250 IU Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 500 IU Consumption and Growth Rate (2017-2022)
-
9.1.3 Global 1000 IU Consumption and Growth Rate (2017-2022)
-
9.1.4 Global 1500 IU Consumption and Growth Rate (2017-2022)
-
9.1.5 Global 2000 IU Consumption and Growth Rate (2017-2022)
-
9.1.6 Global 3000 IU Consumption and Growth Rate (2017-2022)
-
9.1.7 Global 4000 IU Consumption and Growth Rate (2017-2022)
-
9.1.8 Global Other potencies Consumption and Growth Rate (2017-2022)
-
9.2 Global Antihemophilic Factor Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Adult Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Pediatric Consumption and Growth Rate (2017-2022)
10 Global Antihemophilic Factor Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Antihemophilic Factor Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global 250 IU Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global 500 IU Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global 1000 IU Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global 1500 IU Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global 2000 IU Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global 3000 IU Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global 4000 IU Consumption Forecast and Growth Rate (2022-2028)
-
10.1.8 Global Other potencies Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Antihemophilic Factor Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Adult Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Pediatric Consumption Forecast and Growth Rate (2022-2028)
11 Global Antihemophilic Factor Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Antihemophilic Factor Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Antihemophilic Factor Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Antihemophilic Factor Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Antihemophilic Factor Drug Market Competitive Analysis
-
14.1 Grifols
-
14.1.1 Grifols Company Details
-
14.1.2 Grifols Antihemophilic Factor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Grifols Antihemophilic Factor Drug Product and Service
-
14.2 Cigna
-
14.2.1 Cigna Company Details
-
14.2.2 Cigna Antihemophilic Factor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Cigna Antihemophilic Factor Drug Product and Service
-
14.3 Bayer
-
14.3.1 Bayer Company Details
-
14.3.2 Bayer Antihemophilic Factor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Bayer Antihemophilic Factor Drug Product and Service
-
14.4 Hualan Biological Engineering
-
14.4.1 Hualan Biological Engineering Company Details
-
14.4.2 Hualan Biological Engineering Antihemophilic Factor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Hualan Biological Engineering Antihemophilic Factor Drug Product and Service
-
14.5 Octapharma
-
14.5.1 Octapharma Company Details
-
14.5.2 Octapharma Antihemophilic Factor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Octapharma Antihemophilic Factor Drug Product and Service
-
14.6 CSL Behring
-
14.6.1 CSL Behring Company Details
-
14.6.2 CSL Behring Antihemophilic Factor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 CSL Behring Antihemophilic Factor Drug Product and Service
-
14.7 Novo Nordisk
-
14.7.1 Novo Nordisk Company Details
-
14.7.2 Novo Nordisk Antihemophilic Factor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Novo Nordisk Antihemophilic Factor Drug Product and Service
-
14.8 Shire
-
14.8.1 Shire Company Details
-
14.8.2 Shire Antihemophilic Factor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Shire Antihemophilic Factor Drug Product and Service
-
14.9 GC Pharma
-
14.9.1 GC Pharma Company Details
-
14.9.2 GC Pharma Antihemophilic Factor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 GC Pharma Antihemophilic Factor Drug Product and Service
-
14.10 Pfizer
-
14.10.1 Pfizer Company Details
-
14.10.2 Pfizer Antihemophilic Factor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Pfizer Antihemophilic Factor Drug Product and Service
-
14.11 Sanofi
-
14.11.1 Sanofi Company Details
-
14.11.2 Sanofi Antihemophilic Factor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Sanofi Antihemophilic Factor Drug Product and Service
-
14.12 Shanghai RAAS blood products
-
14.12.1 Shanghai RAAS blood products Company Details
-
14.12.2 Shanghai RAAS blood products Antihemophilic Factor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Shanghai RAAS blood products Antihemophilic Factor Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Antihemophilic Factor Drug
-
Figure Antihemophilic Factor Drug Picture
-
Table Global Antihemophilic Factor Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Antihemophilic Factor Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Antihemophilic Factor Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Antihemophilic Factor Drug Consumption by Country (2017-2022)
-
Figure United States Antihemophilic Factor Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Antihemophilic Factor Drug Consumption and Growth Rate (2017-2022)
-
Figure China Antihemophilic Factor Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Antihemophilic Factor Drug Consumption and Growth Rate (2017-2022)
-
Figure India Antihemophilic Factor Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Antihemophilic Factor Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Antihemophilic Factor Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Antihemophilic Factor Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Antihemophilic Factor Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Antihemophilic Factor Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Antihemophilic Factor Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Antihemophilic Factor Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Antihemophilic Factor Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 250 IU Consumption and Growth Rate (2017-2022)
-
Figure Global 500 IU Consumption and Growth Rate (2017-2022)
-
Figure Global 1000 IU Consumption and Growth Rate (2017-2022)
-
Figure Global 1500 IU Consumption and Growth Rate (2017-2022)
-
Figure Global 2000 IU Consumption and Growth Rate (2017-2022)
-
Figure Global 3000 IU Consumption and Growth Rate (2017-2022)
-
Figure Global 4000 IU Consumption and Growth Rate (2017-2022)
-
Figure Global Other potencies Consumption and Growth Rate (2017-2022)
-
Figure Global Adult Consumption and Growth Rate (2017-2022)
-
Figure Global Pediatric Consumption and Growth Rate (2017-2022)
-
Figure Global 250 IU Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 500 IU Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 1000 IU Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 1500 IU Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 2000 IU Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 3000 IU Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 4000 IU Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other potencies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Adult Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pediatric Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Antihemophilic Factor Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Antihemophilic Factor Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Grifols (Foundation Year, Company Profile and etc.)
-
Table Grifols Antihemophilic Factor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Grifols Antihemophilic Factor Drug Product and Service
-
Table Cigna (Foundation Year, Company Profile and etc.)
-
Table Cigna Antihemophilic Factor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cigna Antihemophilic Factor Drug Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Antihemophilic Factor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Antihemophilic Factor Drug Product and Service
-
Table Hualan Biological Engineering (Foundation Year, Company Profile and etc.)
-
Table Hualan Biological Engineering Antihemophilic Factor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hualan Biological Engineering Antihemophilic Factor Drug Product and Service
-
Table Octapharma (Foundation Year, Company Profile and etc.)
-
Table Octapharma Antihemophilic Factor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Octapharma Antihemophilic Factor Drug Product and Service
-
Table CSL Behring (Foundation Year, Company Profile and etc.)
-
Table CSL Behring Antihemophilic Factor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table CSL Behring Antihemophilic Factor Drug Product and Service
-
Table Novo Nordisk (Foundation Year, Company Profile and etc.)
-
Table Novo Nordisk Antihemophilic Factor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk Antihemophilic Factor Drug Product and Service
-
Table Shire (Foundation Year, Company Profile and etc.)
-
Table Shire Antihemophilic Factor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire Antihemophilic Factor Drug Product and Service
-
Table GC Pharma (Foundation Year, Company Profile and etc.)
-
Table GC Pharma Antihemophilic Factor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table GC Pharma Antihemophilic Factor Drug Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Antihemophilic Factor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Antihemophilic Factor Drug Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Antihemophilic Factor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Antihemophilic Factor Drug Product and Service
-
Table Shanghai RAAS blood products (Foundation Year, Company Profile and etc.)
-
Table Shanghai RAAS blood products Antihemophilic Factor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shanghai RAAS blood products Antihemophilic Factor Drug Product and Service
-
